Seegene, Inc.
Seegene, as a leader in multiplex molecular diagnostics, is committed to supporting the global response to the rapidly evolving COVID-19.
The unveiled Seegene’s complete solution for COVID-19 detects and differentiates SARS-CoV-2, influenza, RSV, and other common respiratory pathogens in one integrated platform. Its accurate and reliable test results help reduce further spread of SARS-CoV-2 and provide right information for effective management of influenza-like illness patients.
With Seegene’s core technology and proprietary know-how, we offer multiple diagnostics solutions for infectious diseases, including common respiratory infections, gastrointestinal tract infections, meningitis, HPV, and STIs.